Emergen-C Lawsuit: $6.45M Settlement and Pending Gummy Cases

The biggest Emergen-C lawsuit to date was a $6.45 million false-advertising class action that settled in 2014 and paid consumers in early 2015. That case is closed. Since then, a newer wave of cases filed in 2023 and 2024 has accused the brand of misusing “natural fruit flavors” labels and of selling gummies that contain far less vitamin C than the label claims. Those cases are still pending, so there is no money to claim from them yet.

The $6.45 Million Immune-Boosting Settlement (Closed)

The settlement came out of Wong et al. v. Alacer Corp., filed in San Francisco Superior Court in 2012. The complaint alleged that Alacer Corp., then the maker of Emergen-C, marketed the drink mix as able to reduce the risk of or prevent colds and flu without scientific evidence to back the claims.1Truth in Advertising. Emergen-C Advertising language at issue also included claims that the product could “boost immunity, energy and metabolism.”2ConsumerLab. Emergen-C Settles False Advertising Lawsuit

A San Francisco judge granted preliminary approval in December 2013 and final approval on June 27, 2014.3Top Class Actions. Emergen-C Class Action Lawsuit Settlement The class included anyone who bought Emergen-C between June 1, 2006 and February 27, 2012. Payouts worked like this:

  • With proof of purchase, claimants could recover the full purchase price at per-product values from $4.36 to $12.97, capped at $36.
  • Without proof of purchase, claimants could recover 75% of the average product price, capped at $18.

Total payouts were subject to pro-rata reduction if valid claims exceeded the fund. The claims deadline was October 1, 2014, and payments went out in late January 2015.3Top Class Actions. Emergen-C Class Action Lawsuit Settlement If you didn’t file a claim then, you can’t file one now.

The “Natural Fruit Flavors” Lawsuits (Pending)

Starting in 2023, plaintiffs began challenging Emergen-C’s “natural fruit flavors” labeling. The common allegation is that the products contain DL malic acid, described in the complaints as a synthetic ingredient manufactured from petrochemicals such as benzene or butane.

Scheibe v. Alacer Corporation (Case No. 3:23-cv-00026) was filed on January 6, 2023. It brings claims under the California Business and Professions Code, the California Consumers Legal Remedies Act, and the Pennsylvania Unfair Trade Practices and Consumer Protection Law, and proposes a class of anyone who bought Emergen-C Daily Immune Support in any flavor within four years before filing. No settlement, trial, or dismissal has been reported.4ClassAction.org. Emergen-C Daily Immune Support Falsely Advertised as Made With Natural Fruit Flavors, Class Action Says

Later that year, Jernigan v. GSK Consumer Health Inc. (Case No. 6:23-cv-01640) was filed in the Middle District of Florida, alleging fraud, breach of express warranty, and violations of the Florida Deceptive and Unfair Trade Practices Act over the same DL malic acid issue in a raspberry-flavored beverage mix.5Top Class Actions. Emergen-C Class Action Claims Beverage Mix Falsely Advertised as Containing Natural Fruit Flavors

Two more suits followed in May 2024. Wong et al. v. GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (Case No. 3:24-cv-00943) was filed on May 30, 2024, invoking the California Consumers Legal Remedies Act and federal labeling requirements under the Food, Drug, and Cosmetic Act. The complaint says products containing artificial ingredients that reinforce characterizing flavors must be labeled “artificially flavored.”6ClassAction.org. Emergen-C Lawsuit Says Supplements Are Falsely Advertised With Natural Fruit Flavors Claim Testing commissioned by plaintiffs’ counsel through Krueger Food Laboratories around April 30, 2024 reportedly confirmed the presence of the D isomer of malic acid, indicating synthetic DL malic acid rather than a naturally derived ingredient. The complaint states that the company “continues to advertise, market, promote, and sell its Products in an unlawful and misleading manner” and that the products “continue to bear the false and deceptive statements that they contain only ‘Natural Flavors’ and ‘Natural Fruit Flavors.'”7ClassAction.org. Wong v. GlaxoSmithKline Consumer Healthcare Holdings Complaint

A separate proposed class action was filed on May 31, 2024 in the Southern District of California, naming Haleon and raising the same core allegation.8Law360. Haleon Sued Over Natural Flavors Emergen-C Labels No labeling changes or product reformulations in response to any of these suits have been publicly reported.

The Gummy Vitamin C Shortfall Case (Pending)

Carlos Campos v. Haleon US Inc. et al. (Case No. 4:24-cv-08057-KAW) was filed on November 16, 2024 in the Northern District of California. The complaint cites independent testing showing some Emergen-C gummies contained about 409 milligrams of vitamin C per serving against a label claim of 750 milligrams, a shortfall of nearly 45%. The lawsuit blames the transparent bottle packaging, which the complaint says exposes the gummies to light, oxygen, and heat and causes rapid vitamin C degradation before consumers open the product. The plaintiff argues the products are “misbranded” under federal regulations and that consumers paid premium prices for benefits they did not receive.9Top Class Actions. Emergen-C Advertises More Vitamin C Than Gummy Products Actually Contain, Class Action

The proposed class would cover all U.S. consumers who bought Emergen-C gummies since November 15, 2020. Claims include false advertising, unjust enrichment, and fraudulent business practices. Gutride Safier LLP represents the plaintiff. The case is proposed, not certified, and no settlement has been reached.

The Earlier Gummy Labeling Case

Before Campos, another gummy case went further procedurally. In Cimoli v. Alacer Corp. (Case No. 5:20-cv-07838-BLF), the plaintiff alleged that the front labels of Emergen-C Immune Support Gummy products misled consumers about per-gummy dosage of vitamin C and elderberry, pointing to claims such as “Crafted with 50 mg of elderberry juice concentrate.” On July 1, 2021, Judge Beth Labson Freeman allowed the fraud-based claims to proceed under the California Unfair Competition Law, Consumers Legal Remedies Act, False Advertising Law, and common law fraud. Breach of warranty claims were dismissed with leave to amend, and the request for injunctive relief was dismissed.10FindLaw. Cimoli v. Alacer Corp.

Who Currently Owns Emergen-C

The name on the lawsuit depends on when it was filed. Alacer Corp., the original maker, was acquired by Pfizer in February 2012.11Pfizer. Pfizer Acquires Alacer Corp Pfizer and GlaxoSmithKline merged their consumer healthcare businesses into a joint venture in 2018.12Powder Bulk Solids. GSK to Shutter Emergen-C Powdered Drink Mix Plant That venture was spun off as Haleon, an independent publicly traded company, in July 2022, and Emergen-C sits inside Haleon’s brand portfolio today.13Intuition Labs. Haleon That is why recent cases name some combination of Alacer, GSK, and Haleon.

If You Bought Emergen-C

None of the pending cases has a claims process yet. If any of them settles or a class is certified, notice is typically sent through the settlement administrator and covered by consumer-news outlets. Save your receipts and product packaging in the meantime; the 2014 settlement paid substantially more to claimants who could show proof of purchase, and the pending cases follow the same general pattern in how damages are calculated. If you bought gummies after November 15, 2020 or drink mixes labeled with “natural fruit flavors” within the last several years, you fall within the proposed classes as currently defined, though those definitions can change as the cases move.